Two Doctors from Shonan Beauty Clinic Present Research Findings at International Medical Conference “IMCAS China 2026”

Dr. Sho Matsuura and Dr. Ayano Okuda of the Shinjuku Main Branch share the latest insights on fat grafting and aesthetic gynecology

IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that Dr. Sho Matsuura and Dr. Ayano Okuda of Shonan Beauty Clinic Shinjuku Main Branch, a clinic that receives management support from the Company, presented research findings at the international medical conference “IMCAS China 2026,” held in Shanghai, China, from August 27 to 29, 2026.

IMCAS (International Master Course on Aging Science) is one of the world’s largest international medical conferences in fields such as aesthetic dermatology, plastic surgery, aesthetic surgery, and anti-aging medicine. It is highly regarded as a forum where doctors, researchers, and healthcare professionals from Asia and around the world share the latest treatment techniques and clinical insights. At “IMCAS China 2026,” Dr. Matsuura and Dr. Okuda each presented the latest findings based on clinical experience and research in their respective fields of expertise, and engaged in active discussions with participants from Japan and overseas on new treatment approaches and clinical implications.

As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic activities and international exchanges with research institutions, and to upholding the safety, transparency, and enduring value of aesthetic healthcare.

Overview of “IMCAS China 2026”
Venue: W Hotel - The Bund (Shanghai, China)
Dates: August 27 (Thu) to 29 (Sat), 2026
Official website: https://www.imcas.com/en/imcas-china-2026

Presentation Titles
Dr. Sho Matsuura (Shonan Beauty Clinic Shinjuku Main Branch)
・“Association between injection-plane allocation and volumetric outcome after autologous breast fat grafting”
・“Association between postoperative weight trajectory and 6-month volumetric outcome after autologous breast fat grafting”

Dr. Ayano Okuda (Shonan Beauty Clinic Shinjuku Main Branch)
・“‘Aesthetic, functional, and unspoken’: patient-reported motivations, non-disclosure, and anatomical literacy in 103 Japanese women seeking labiaplasty”

About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp